2 months ago
TECH
AnalystsDavid ToungDavid Toung's Stock Forecasts
AnalystsDavid Toung
Analyst Ranking
Top 19%
#975 out of 5177 analysts
Average Return
+6.37%
Win Rate
64%51 out of 80
Risk vs Reward
Poor
Good
David Toung's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Eli Lilly & CoLLY | +69.53% | $558.19 | $946.31 | 2023-09-04 - 2024-09-04 | Strong Buy |
Mckesson CorpMCK | +56.21% | $196.53 | $307.00 | 2021-03-29 - 2022-03-29 | Strong Buy |
Cardinal Health IncCAH | +52.83% | $97.11 | $148.41 | 2024-05-14 - 2025-05-14 | Strong Buy |
Thermo Fisher Scientific IncTMO | +46.11% | $427.53 | $624.65 | 2025-04-28 - 2026-01-15 | Strong Buy |
Amgen IncAMGN | +42.09% | $224.73 | $319.31 | 2023-06-25 - 2024-06-25 | Strong Buy |
David Toung Analyst Color
Get additional color on David Toung's coverage of popular stocks
a year ago
UNH
2 years ago
MCK
2 years ago
LLY
2 years ago
HOLX
2 years ago
MCK
2 years ago
CRL
2 years ago
MCK
2 years ago
LLY
3 years ago
MCK
3 years ago
SYK
3 years ago
HCA
3 years ago
SYK
3 years ago
HCA
3 years ago
ISRG
3 years ago
MCK
3 years ago
UNH
David Toung's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bio Techne CorpTECH | 4 | Strong Buy | $68.00 | -2.80% | Maintains | 2 months ago |
Thermo Fisher Scientific IncTMO | 7 | Strong Buy | $610.00 | -2.35% | Maintains | 3 months ago |
Hologic IncHOLX | 2 | Strong Buy | $90.00 | +19.97% | Maintains | 4 months ago |
Medtronic PLCMDT | 5 | Strong Buy | $115.00 | +16.16% | Maintains | 5 months ago |
Humana IncHUM | 4 | Hold | $281.99 | -0.69% | Reiterates | 5 months ago |
Globalfoundries IncGFS | 1 | Strong Buy | $52.00 | +25.21% | Initiates Coverage On | 7 months ago |
Elevance Health IncELV | 3 | Strong Buy | $465.00 | +21.75% | Maintains | 9 months ago |
Cardinal Health IncCAH | 5 | Strong Buy | $125.00 | N/A | Maintains | a year ago |
Unitedhealth Group IncUNH | 4 | Strong Buy | $600.00 | N/A | Maintains | a year ago |
Amgen IncAMGN | 7 | Strong Buy | $340.00 | N/A | Maintains | 2 years ago |
Mckesson CorpMCK | 6 | Strong Buy | $670.00 | N/A | Maintains | 2 years ago |
Zimmer Biomet Holdings IncZBH | 3 | Strong Buy | $150.00 | N/A | Upgrades | 2 years ago |
Eli Lilly & CoLLY | 3 | Strong Buy | $840.00 | N/A | Maintains | 2 years ago |
Ge Healthcare Technologies IncGEHC | 1 | Strong Buy | $110.00 | N/A | Maintains | 2 years ago |
Charles River Laboratories International IncCRL | 2 | Strong Buy | $290.00 | N/A | Maintains | 2 years ago |
Catalent IncCTLT | 2 | Strong Buy | $62.00 | N/A | Upgrades | 2 years ago |
Stryker CorpSYK | 2 | Strong Buy | $310.00 | N/A | Maintains | 3 years ago |
Silk Road Medical IncSILK | 3 | Strong Buy | $55.00 | N/A | Maintains | 3 years ago |
Hca Healthcare IncHCA | 2 | Strong Buy | $310.00 | N/A | Maintains | 3 years ago |
Cencora IncCOR | 4 | Strong Buy | $190.00 | N/A | Maintains | 3 years ago |
Intuitive Surgical IncISRG | 2 | Strong Buy | $320.00 | N/A | Maintains | 3 years ago |
Abbott LaboratoriesABT | 3 | Strong Buy | $135.00 | N/A | Maintains | 3 years ago |
Gilead Sciences IncGILD | 1 | Strong Buy | $75.00 | N/A | Upgrades | 4 years ago |
Bristol Myers Squibb CoBMY | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Merck & Co IncMRK | 3 | Strong Buy | $110.00 | N/A | Upgrades | 4 years ago |
Teladoc Health IncTDOC | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Novartis AgNVS | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Abbvie IncABBV | 4 | Strong Buy | $115.00 | N/A | Upgrades | 6 years ago |
Johnson & JohnsonJNJ | 2 | Strong Buy | $155.00 | N/A | Reiterates | 6 years ago |
Wellcare Health Plans IncWCG | 1 | Strong Buy | $360.00 | N/A | Maintains | 7 years ago |
Celgene CorpCELG | 3 | Hold | N/A | N/A | Downgrades | 8 years ago |
Allergan PLCAGN | 1 | Hold | N/A | N/A | Downgrades | 8 years ago |
Aetna IncAET | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.